Ligand Pharmaceuticals (LGND) Technical (Analysis) Reports Ligand Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Ligand Pharmaceuticals (LGND)
Technical Analysis Report for USA stock LGND Ligand Pharmaceuticals. Dated: 07 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock LGND Ligand Pharmaceuticals then click here. or read Experts views on Ligand Pharmaceuticals or Forecast & share price targets of Ligand Pharmaceuticals
Ligand Pharmaceuticals Opened at 304.37 and Closed at: 293.15, which is -2.38% of previous session's close. It moved within a range of 286.65 and 304.60
The session was a Bearish session with an average volume of 313600, which is -25.54% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 280.93 and resistance for tomorrow is 298.88
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 285, 276.85 resistance for tomorrow's hourly charts is 302.95, 312.75
10 Day SMA for Ligand Pharmaceuticals (LGND) is 295.43 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Ligand Pharmaceuticals (LGND) is 297.92 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Ligand Pharmaceuticals (LGND) is 284.73 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 251.48 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Ligand Pharmaceuticals is 223.66 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Ligand Pharmaceuticals is at 297.92 and 200 DMA is at 223.66, while 50 DMA and 100 DMA are at 284.73 and 251.48 respectively
Ligand Pharmaceuticals (LGND) moving average of 20 SMA is at 297.92 and 20 EMA is at 297.04
| Date | Closing Price | 20 SMA | 20 EMA |
| 07 Fri Aug | 293.15 | 297.92 | 297.04 |
| 06 Thu Aug | 300.14 | 298.72 | 297.45 |
| 05 Wed Aug | 302.57 | 299.53 | 297.17 |
| 04 Tue Aug | 300.79 | 300.53 | 296.6 |
| 03 Mon Aug | 292.04 | 301.24 | 296.16 |
| 31 Fri Jul | 287.54 | 302.61 | 296.59 |
Ligand Pharmaceuticals (LGND) moving average of 50 SMA is at 284.73 and 50 EMA is at 283.53
| Date | Closing Price | 50 SMA | 50 EMA |
| 07 Fri Aug | 293.15 | 284.73 | 283.53 |
| 06 Thu Aug | 300.14 | 283.56 | 283.14 |
| 05 Wed Aug | 302.57 | 282.28 | 282.45 |
| 04 Tue Aug | 300.79 | 280.93 | 281.63 |
| 03 Mon Aug | 292.04 | 279.51 | 280.85 |
| 31 Fri Jul | 287.54 | 278.11 | 280.39 |
Ligand Pharmaceuticals (LGND) moving average of 100 SMA is at 251.48 and 100 EMA is at 260.35
| Date | Closing Price | 100 SMA | 100 EMA |
| 07 Fri Aug | 293.15 | 251.48 | 260.35 |
| 06 Thu Aug | 300.14 | 250.66 | 259.69 |
| 05 Wed Aug | 302.57 | 249.74 | 258.87 |
| 04 Tue Aug | 300.79 | 248.74 | 257.99 |
| 03 Mon Aug | 292.04 | 247.85 | 257.13 |
| 31 Fri Jul | 287.54 | 247.14 | 256.42 |
Ligand Pharmaceuticals (LGND) moving average of 200 SMA is at 223.66 and 200 EMA is at 228.68
| Date | Closing Price | 200 SMA | 200 EMA |
| 07 Fri Aug | 293.15 | 223.66 | 228.68 |
| 06 Thu Aug | 300.14 | 223.13 | 228.03 |
| 05 Wed Aug | 302.57 | 222.56 | 227.3 |
| 04 Tue Aug | 300.79 | 221.96 | 226.54 |
| 03 Mon Aug | 292.04 | 221.36 | 225.79 |
| 31 Fri Jul | 287.54 | 220.82 | 225.12 |
Arcus Biosciences has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Arcus Biosciences, about 3.62% more returns!
Brookdale Senior has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Brookdale Senior, about 2.81% more returns!
Urogen Pharma has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Urogen Pharma, about 22.43% more returns!
Ligand Pharmaceuticals has performed better than Solid Biosciences in short term. Holding Ligand Pharmaceuticals could be a better choice for now!
Surgery Partners has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Surgery Partners, about 5.31% more returns!
Replimune Group has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Replimune Group, about 24.89% more returns!
Petmed Express has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Petmed Express, about 4.14% more returns!
Pacira Pharmaceuticals has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 2.64% more returns!
Ligand Pharmaceuticals has performed better than Livanova Plc in short term. Holding Ligand Pharmaceuticals could be a better choice for now!
Ligand Pharmaceuticals has performed better than Healthcare Services in short term. Holding Ligand Pharmaceuticals could be a better choice for now!
Halozyme Therapeutics has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 40% more returns!
Eton Pharmaceuticals has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 21.5% more returns!
Enanta Pharmaceuticals has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 7.63% more returns!
Ligand Pharmaceuticals has performed better than Capricor Therapeutics in short term. Holding Ligand Pharmaceuticals could be a better choice for now!
Biomerica Inc has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Biomerica Inc, about 1.37% more returns!
Anavex Life has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Anavex Life, about 40.05% more returns!
Ligand Pharmaceuticals has performed better than Alkermes Plc in short term. Holding Ligand Pharmaceuticals could be a better choice for now!
Agenus Inc has performed better than Ligand Pharmaceuticals in short term. You could have earned much better returns by investing in Agenus Inc, about 39.68% more returns!
Ligand Pharmaceuticals Technical analysis of indicators
Price action analysis of Ligand Pharmaceuticals (LGND) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 295.49 and Ligand Pharmaceuticals LGND stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ligand Pharmaceuticals LGND stock. Volume based technical analysis of Ligand Pharmaceuticals LGND stock is negative.
Ligand Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock LGND Ligand Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And LGND Experts View which covers a lot of information including buying and selling signals
LGND future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Ligand Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Ligand Pharmaceuticals (LGND) Technical (Analysis) Reports Ligand Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


